In last trading session, Solid Biosciences Inc. (NASDAQ:SLDB) saw 1.18 million shares changing hands with its beta currently measuring 0.91. Company’s recent per share price level of $1.41 trading at -$0.08 or -5.37% at ring of the bell on the day assigns it a market valuation of $159.47M. That closing price of SLDB’s stock is at a discount of -721.28% from its 52-week high price of $11.58 and is indicating a discount of -4.96% from its 52-week low price of $1.48. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.05 million shares which gives us an average trading volume of 1.51 million if we extend that period to 3-months.
Solid Biosciences Inc. (NASDAQ:SLDB) trade information
Upright in the red during last session for losing -5.37%, in the last five days SLDB remained trading in the red while hitting it’s week-highest on Tuesday, 01/11/22 when the stock touched $1.41 price level, adding 21.67% to its value on the day. Solid Biosciences Inc.’s shares saw a change of -19.43% in year-to-date performance and have moved -12.96% in past 5-day. Solid Biosciences Inc. (NASDAQ:SLDB) showed a performance of -20.34% in past 30-days. Number of shares sold short was 6.17 million shares which calculate 2.72 days to cover the short interests.
Solid Biosciences Inc. (SLDB) estimates and forecasts
Statistics highlight that Solid Biosciences Inc. is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -54.52% of value to its shares in past 6 months, showing an annual growth rate of 56.63% while that of industry is 7.90. Apart from that, the company came raising its revenue forecast for fiscal year 2022. The company is estimating its revenue growth to increase by 35.50% in the current quarter and calculating -26.30% decrease in the next quarter.
6 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $2.24 million for the same. And 3 analysts are in estimates of company making revenue of $3.47 million in the next quarter that will end on Mar 2022.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -53.40% during past 5 years.
Solid Biosciences Inc. is more likely to be releasing its next quarterly report on November 03 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Solid Biosciences Inc. (NASDAQ:SLDB)’s Major holders
Insiders are in possession of 12.74% of company’s total shares while institution are holding 70.63 percent of that, with stock having share float percentage of 80.93%. Investors also watch the number of corporate investors in a company very closely, which is 70.63% institutions for Solid Biosciences Inc. that are currently holding shares of the company. Perceptive Advisors Llc is the top institutional holder at SLDB for having 13.41 million shares of worth $32.06 million. And as of Sep 29, 2021, it was holding 12.16% of the company’s outstanding shares.
The second largest institutional holder is RA Capital Management, L.P., which was holding about 12.37 million shares on Sep 29, 2021. The number of shares represents firm’s hold over 11.21% of outstanding shares, having a total worth of $29.56 million.
On the other hand, Price (T.Rowe) New Horizons Fund and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Sep 29, 2021, the former fund manager was holding 1.97 million shares of worth $4.71 million or 1.79% of the total outstanding shares. The later fund manager was in possession of 1.39 million shares on Oct 30, 2021, making its stake of worth around $2.82 million in the company or a holder of 1.26% of company’s stock.